FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, namely to composition for preventing and treating diseases of the thyroid gland. Pharmaceutical composition for the prophylaxis and treatment of diseases of the thyroid gland, comprising the active ingredient and the desired additives, which is in the form of capsules, containing as active ingredient a therapeutically effective amount of Lycopus europaeus herb extract dry, and as the target additives – lactose monohydrate 80 M, magnesium vegetable stearate and aerosil A 380 at a certain ratio of components.
EFFECT: composition described above ensures effectiveness of application and homogeneity of the mass after long-term storage.
1 cl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING THYROID HYPOTHYREOSIS | 2018 |
|
RU2708260C1 |
METHOD FOR PRODUCING DRY REFINED EXTRACT OF EUROPEAN BUGLEWEED HERB EXHIBITING THYREOTROPIC ACTION | 2014 |
|
RU2574028C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF SOLID PERORAL MEDICINAL FORM, CONTAINING SYGETHINUM (VERSIONS) | 2007 |
|
RU2338523C1 |
METHOD FOR ENCAPSULATING DRY PLANT EXTRACTS | 2022 |
|
RU2782431C1 |
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
ANTIVIRAL DRUG AS CAPSULES AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2633085C2 |
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT OF ENCAPSULATED FORM | 2020 |
|
RU2756855C1 |
ENCAPSULATED FORM FOOD BAA | 2020 |
|
RU2752781C1 |
SEDATIVE AGENT | 2022 |
|
RU2784433C1 |
DRUG PREPARATION IN FORM OF CAPSULES EXHIBITING ANTIVIRAL AND INTERFERONOGENIC ACTION | 2010 |
|
RU2446803C1 |
Authors
Dates
2018-05-24—Published
2017-06-22—Filed